Literature DB >> 8788073

Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene.

A Heils1, A Teufel, S Petri, M Seemann, D Bengel, U Balling, P Riederer, K P Lesch.   

Abstract

We have isolated and characterized the 5'-flanking region and the proximal polyadenylation site of the human 5-HT transporter gene. The major gene transcript is 2,793 bp in length and it contains 208 bp of 5'-untranslated region (5'-UTR) and 694 bases of 3'-UTR. While only a single mRNA species occurs in rats and mice, the most proximal signal for polyadenylation in the human gene appears to be highly degenerate in comparison to the rat and murine motif. This polyadenylation signal-like motif may lead to alternate usage of additional polyadenylation sites resulting in multiple mRNA species in humans. A TATA-like motif and several potential binding sites for transcription factors including AP1, AP2, SP1, and a cAMP response element (CRE)-like motif are present in the 5'-flanking region. A approximately 1.7 kb fragment beginning 217 bp downstream from the transcription start site, which had been ligated into a luciferase reporter vector and transiently expressed in JAR human placental choriocarcinoma cells, displayed both constitutive and forskolin/cholera toxin-induced promoter activity. Functional promoter mapping revealed that there are negative attenuating elements between bp -1,428 and -1,185 and positive elements between bp -1,184 and -78 from the transcription initiation site. Studies with deletional mutants also indicated that core promoter sequences are contained within 78 bp of the transcription start site and that regulation of cAMP-inducible promoter activity depends on multiple cis-acting elements including two AP1 binding sites and a single CRE-like element located at bp -99. Our findings suggest that (1) the 5-HT transporter gene promoter is active in human JAR cells, but inactive in 5-HT transporter-deficient human SK-N-SH neuroblastoma and HeLa cells, (2) the information contained within 1.4 kb of 5'-flanking sequence is sufficient to confer its cell-specific expression, (3) the promoter responds to cAMP induction, and (4) the expression of the 5-HT transporter gene is regulated by a combination of positive and negative cis-acting elements operating through a basal promoter unit defined by a TATA-like motif.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788073     DOI: 10.1007/bf01281159

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  9 in total

Review 1.  How the messenger got its tail: addition of poly(A) in the nucleus.

Authors:  M Wickens
Journal:  Trends Biochem Sci       Date:  1990-07       Impact factor: 13.807

2.  Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding.

Authors:  S Ramamoorthy; D R Cool; V B Mahesh; F H Leibach; H E Melikian; R D Blakely; V Ganapathy
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

3.  Expression of serotonin transporter messenger RNA in the human brain.

Authors:  M C Austin; C C Bradley; J J Mann; R D Blakely
Journal:  J Neurochem       Date:  1994-06       Impact factor: 5.372

4.  Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR).

Authors:  D R Cool; F H Leibach; V K Bhalla; V B Mahesh; V Ganapathy
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

5.  Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE.

Authors:  D Di Bella; M Catalano; U Balling; E Smeraldi; K P Lesch
Journal:  Am J Med Genet       Date:  1996-11-22

6.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Primary structure of the serotonin transporter in unipolar depression and bipolar disorder.

Authors:  K P Lesch; J Gross; E Franzek; B L Wolozin; P Riederer; D L Murphy
Journal:  Biol Psychiatry       Date:  1995-02-15       Impact factor: 13.382

8.  Isolation of a cDNA encoding the human brain serotonin transporter.

Authors:  K P Lesch; B L Wolozin; H C Estler; D L Murphy; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Organization of the human serotonin transporter gene.

Authors:  K P Lesch; U Balling; J Gross; K Strauss; B L Wolozin; D L Murphy; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1994
  9 in total
  60 in total

1.  Mapping genes of complex psychiatric diseases in Daghestan genetic isolates.

Authors:  Kazima B Bulayeva; Suzanne M Leal; Tatiana A Pavlova; Ruslan M Kurbanov; Stephen J Glatt; Oleg A Bulayev; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-01-05       Impact factor: 3.568

2.  Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia.

Authors:  Tempei Ikegame; Miki Bundo; Naohiro Okada; Yui Murata; Shinsuke Koike; Hiroko Sugawara; Takeo Saito; Masashi Ikeda; Keiho Owada; Masaki Fukunaga; Fumio Yamashita; Daisuke Koshiyama; Tatsunobu Natsubori; Norichika Iwashiro; Tatsuro Asai; Akane Yoshikawa; Fumichika Nishimura; Yoshiya Kawamura; Jun Ishigooka; Chihiro Kakiuchi; Tsukasa Sasaki; Osamu Abe; Ryota Hashimoto; Nakao Iwata; Hidenori Yamasue; Tadafumi Kato; Kiyoto Kasai; Kazuya Iwamoto
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

3.  Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.

Authors:  Alexandra Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

Review 4.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

5.  5-HTTLPR differentially predicts brain network responses to emotional faces.

Authors:  Patrick M Fisher; Cheryl L Grady; Martin K Madsen; Stephen C Strother; Gitte M Knudsen
Journal:  Hum Brain Mapp       Date:  2015-04-30       Impact factor: 5.038

6.  Is the serotonin transporter polymorphism (5-HTTLPR) associated with harm avoidance and internalising problems in childhood and adolescence?

Authors:  K Becker; M El-Faddagh; M H Schmidt; M Laucht
Journal:  J Neural Transm (Vienna)       Date:  2006-10-19       Impact factor: 3.575

7.  Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in adult female rhesus monkeys (Macaca mulatta).

Authors:  J B Hoffman; J R Kaplan; B Kinkead; S L Berga; M E Wilson
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

8.  A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.

Authors:  Johan Lundberg; Jacqueline Borg; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2007-09-15       Impact factor: 4.530

9.  Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Authors:  Sandeep Gyawali; Ryan Subaran; Myrna M Weissman; Dylan Hershkowitz; Morgan C McKenna; Ardesheer Talati; Abby J Fyer; Priya Wickramaratne; Phillip B Adams; Susan E Hodge; Carl J Schmidt; Michael J Bannon; Charles E Glatt
Journal:  Biol Psychiatry       Date:  2009-12-06       Impact factor: 13.382

10.  Smoking as a product of gene-environment interaction.

Authors:  Kent W Nilsson; Lars Oreland; Robert Kronstrand; Jerzy Leppert
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.